ALK fusion in a cohort of 469 Finnish patients with non-small cell lung cancer

被引：0
|
作者：
Merkkiniemi, K. [1 ]
Kero, M. [2 ]
Maki-Nevala, S. [1 ]
Sarhadi, V. K. [1 ]
Tikkanen, M. [1 ]
Wirtanen, T. [1 ]
Ronty, M. [2 ]
Knuuttila, A. [3 ]
Knuutila, S. [1 ]
机构：
[1] Haartman Inst, Dept Pathol, Helsinki, Finland
[2] HUSLAB Helsinki Univ, Cent Hosp, Dept Pathol, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
672
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [21] Trends in ALK inhibitors for non-small cell lung cancer.
    Meade, Denise
    Ng, Marie
    Alford, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Treatment of ALK-Positive Non-Small Cell Lung Cancer
    Bang, Yung-Jue
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (10) : 1201 - 1204
  • [23] ALK inhibitors and advanced non-small cell lung cancer (Review)
    Rossi, Antonio
    Maione, Paolo
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    Ciardiello, Fortunato
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 499 - 508
  • [24] ALK COPY NUMBER CHANGES IN NON-SMALL CELL LUNG CANCER
    Arriola, Edurne
    Taus, Alvaro
    Salido, Marta
    Galvan, Ana B.
    Martinez-Aviles, Luz
    Gimeno, Javier
    Serrano, Sergio
    Bellosillo, Beatriz
    Sole, Francesc
    Albanell, Joan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S507 - S508
  • [25] Treating ALK-positive non-small cell lung cancer
    Ziogas, Dimitrios C.
    Tsiara, Anna
    Tsironis, Georgios
    Lykka, Maria
    Liontos, Michalis
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [26] Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
    Kitadai, Rui
    Okuma, Yusuke
    Kashima, Jumpei
    CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 171 - 177
  • [27] ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer
    Guerin, Annie
    Sasane, Medha
    Zhang, Jie
    Macalalad, Alexander R.
    Galebach, Philip
    Jarvis, John
    Kageleiry, Andrew
    Culver, Kenneth
    Wu, Eric Q.
    Wakelee, Heather
    CANCER EPIDEMIOLOGY, 2015, 39 (03) : 307 - 312
  • [28] Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
    Mezquita, L.
    Remon, J.
    Nicotra, C.
    Noerholm, M.
    Brinkmann, K.
    Planchard, D.
    Jovelet, C.
    Auclin, E.
    Flinspach, C.
    Hurley, J.
    Skog, J.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Lacroix, L.
    Auger, N.
    Friboulet, L.
    Soria, J.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1954 - S1955
  • [29] Effect of EML-Alk Fusion Variant and Fusion Abundance on the Efficacy of Crizotinib in Non-Small Cell Lung Cancer
    Lv, T.
    Zou, Q.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1894 - S1894
  • [30] SPECC1L-ALK: A novel gene fusion response to ALK inhibitors in non-small cell lung cancer
    Ma, Li
    Zhang, Quan
    Dong, Yujie
    Li, Haoyang
    Wang, Jinghui
    LUNG CANCER, 2020, 143 : 97 - 100
12345